» Articles » PMID: 30247075

Exosomes at a Glance - Common Nominators for Cancer Hallmarks and Novel Diagnosis Tools

Overview
Publisher Informa Healthcare
Date 2018 Sep 25
PMID 30247075
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer represents a heterogeneous disease with multiple levels of regulation and a dynamic environment that sustains the evolution of the malignant mass. This dynamic is in part sustained by a class of extracellular vesicles termed exosomes that are able to imprint the pathological state by incorporating differential cargos in order to facilitate cell-to-cell communication. Exosomes are stable within the extracellular medium and function as shuttles secreted by healthy or pathological cells, being further taken by the accepting cell with direct effects on its phenotype. The exosomal trafficking is deeply involved in multiple levels of cancer development with roles in all cancer hallmarks. Nowadays, studies are constantly exploring the ability of exosomes to sustain the malignant progression in order to attack this pathological trafficking and impair the ability of the tumor mass to expand within the organisms. As important, the circulatory characteristics of exosomes represent a steady advantage regarding the possibility of using them as minimally invasive diagnosis tools, where cancer patients' present modified exosomal profiles compared to the healthy ones. This last characteristic, as novel diagnosis tools, has the advantage of a possible rapid transition within the clinic, compared to the studies that evaluate the therapeutic meaning.

Citing Articles

Role of miR-181 Family Members in Stroke: Insights into Mechanisms and Therapeutic Potential.

Braicu C, Muresanu F, Isachesku E, Bornstein N, Filipovic S, Strilciuc S Int J Mol Sci. 2025; 26(2).

PMID: 39859155 PMC: 11765211. DOI: 10.3390/ijms26020440.


TRPC3 signalling contributes to the biogenesis of extracellular vesicles.

Padbury E, Balint S, Carollo E, Carter D, Becker E J Extracell Biol. 2024; 3(1):e132.

PMID: 38938673 PMC: 11080740. DOI: 10.1002/jex2.132.


Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence.

Deng M, Wu S, Huang P, Liu Y, Li C, Zheng J Asian J Pharm Sci. 2024; 18(6):100870.

PMID: 38161784 PMC: 10755545. DOI: 10.1016/j.ajps.2023.100870.


Gastric Cancer-Derived Extracellular Vesicles (EVs) Promote Angiogenesis via Angiopoietin-2.

Kalfon T, Loewenstein S, Gerstenhaber F, Leibou S, Geller H, Sher O Cancers (Basel). 2022; 14(12).

PMID: 35740619 PMC: 9221039. DOI: 10.3390/cancers14122953.


Emerging roles of exosome-derived biomarkers in cancer theranostics: messages from novel protein targets.

Cheng J, Wang X, Yuan X, Liu G, Chu Q Am J Cancer Res. 2022; 12(5):2226-2248.

PMID: 35693088 PMC: 9185602.